Cancer Stem Cell Phenotypes in ER+ Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Molecular Cancer Research

• Publication date

  2018-01-18

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/1541-7786.MCR-17-0598PMID 29348189PMCID PMC5882512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells.

  2017cited by this paper
• Overview of Cancer Stem Cells and Stemness for Community Oncologists

  2017cited by this paper
• Cytoplasmic Localization of Proline, Glutamic Acid, Leucine-rich Protein 1 (PELP1) Induces Breast Epithelial Cell Migration through Up-regulation of Inhibitor of κB Kinase ϵ and Inflammatory Cross-talk with Macrophages*

  2016cited by this paper
• Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3

  2016cited by this paper
• PELP1: Structure, biological function and clinical significance.

  2016cited by this paper
• De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas

  2016cited by this paper
• Regulation of breast cancer stem cell features

  2015cited by this paper
• The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype

  2015cited by this paper
• AMIGO2, a novel membrane anchor of PDK1, controls cell survival and angiogenesis via Akt activation

  2015cited by this paper
• Cytoplasmic PELP1 and ERRgamma Protect Human Mammary Epithelial Cells from Tam-Induced Cell Death

  2015cited by this paper
• Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?

  2015cited by this paper
• New Findings on Breast Cancer Stem Cells: A Review

  2015cited by this paper
• Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes

  2014cited by this paper
• Lack of correlation of stem cell markers in breast cancer stem cells

  2014cited by this paper
• Inhibition of mTOR Signaling Reduces PELP1-Mediated Tumor Growth and Therapy Resistance

  2014cited by this paper
• PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma.

  2014cited by this paper
• PELP1: a review of PELP1 interactions, signaling, and biology.

  2014cited by this paper
• uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies

  2014cited by this paper
• Peptidomimetic targeting of critical androgen receptor–coregulator interactions in prostate cancer

  2013cited by this paper
• Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer

  2012cited by this paper
• Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming.

  2012cited by this paper
• LAS1L interacts with the mammalian Rix1 complex to regulate ribosome biogenesis

  2012cited by this paper
• Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression

  2012cited by this paper
• The role of AIB1 in breast cancer.

  2012cited by this paper
• Choosing the right cell line for breast cancer research

  2011cited by this paper
• An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

  2010cited by this paper
• The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype

  2010cited by this paper
• Estrogen-dependent Transcription of the NEL-like 2 (NELL2) Gene and Its Role in Protection from Cell Death*

  2010cited by this paper
• Estrogen-dependent and estrogen-independent mechanisms contribute to AIB1-mediated tumor formation.

  2010cited by this paper
• New Strategies in Estrogen Receptor–Positive Breast Cancer

  2010cited by this paper
• Predicting endocrine therapy responsiveness in breast cancer.

  2009cited by this paper
• AIB1 is required for the acquisition of epithelial growth factor receptor-mediated tamoxifen resistance in breast cancer cells.

  2009cited by this paper
• Biological determinants of endocrine resistance in breast cancer

  2009cited by this paper
• Extranuclear Coactivator Signaling Confers Insensitivity to Tamoxifen

  2009cited by this paper
• Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.

  2008cited by this paper
• Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells

  2008cited by this paper
• Role of AIB1 for Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells

  2008cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland.

  2006cited by this paper
• Rapid Estrogen-Induced Phosphorylation of the SRC-3 Coactivator Occurs in an Extranuclear Complex Containing Estrogen Receptor

  2005cited by this paper
• Functional implications of altered subcellular localization of PELP1 in breast cancer cells.

  2005influential reference
• ACTR/AIB1 Functions as an E2F1 Coactivator To Promote Breast Cancer Cell Proliferation and Antiestrogen Resistance

  2004cited by this paper
• Urokinase-Type Plasminogen Activator System in Breast Cancer

  2004cited by this paper
• Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways.

  2004cited by this paper
• High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.

  2004cited by this paper
• Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.

  2003cited by this paper
• Estrogen receptor-mediated cross-talk with growth factor signaling pathways

  2001cited by this paper
• AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

  1997cited by this paper
• Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase

  1995influential reference
• Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer.

  1995cited by this paper
• Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance.

  1982cited by this paper

• The PELP1 Pathway and Its Importance in Cancer Treatment

  2025influential citation
• Proline-, Glutamic Acid-, Leucine-Rich Protein 1 (PELP1): Diversity, Structural Conservation, and Evolutionary Origins Across the Species

  2025cites this paper
• Emerging mechanisms of therapy resistance in metastatic ER+ breast cancer.

  2025cites this paper
• Post-translational modifications: The potential ways for killing cancer stem cells

  2024cites this paper
• Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target

  2023cites this paper
• Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma

  2023cites this paper
• Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies

  2022cites this paper
• Nuclear-localized, iron-bound superoxide dismutase-2 antagonizes epithelial lineage programs to promote stemness of breast cancer cells via a histone demethylase activity

  2022cites this paper
• Mechanosensitive steroid hormone signaling and cell fate.

  2022cites this paper
• SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance

  2022cites this paper
• Cryo-EM reveals the architecture of the PELP1-WDR18 molecular scaffold

  2022cites this paper
• Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies

  2021cites this paper
• SRC-3, a Steroid Receptor Coactivator: Implication in Cancer

  2021cites this paper
• Fatty acid β-oxidation promotes breast cancer stemness and metastasis via the miRNA-328-3p-CPT1A pathway

  2021cites this paper
• PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer

  2021cites this paper
• Stress sensing within the breast tumor microenvironment: how glucocorticoid receptors live in the moment.

  2021cites this paper
• Role of estrogen receptor coregulators in endocrine resistant breast cancer

  2021cites this paper
• Unique transcriptomic changes underlie hormonal interactions during mammary histomorphogenesis in female pigs.

  2021cites this paper
• PELP1/SRC-3-dependent regulation of metabolic kinases drives therapy resistant ER+ breast cancer

  2020cites this paper
• Melatonin abrogates liver, ovarian, and uterine toxicities induced by tamoxifen in a breast cancer mouse model

  2020cites this paper
• Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling

  2020cites this paper
• Steroid Receptors as MAPK Signaling Sensors in Breast Cancer: Let the Fates Decide.

  2020cites this paper
• The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer

  2019cites this paper
• Targeting steroid receptor co-activators to inhibit breast cancer stem cells

  2018cites this paper
• The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer Subtypes

  2018cites this paper